Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jae-Seung Chung
Pd71-06 CTC-Based Gene Expression for Predicting Resistance to Abiraterone and Enzalutamide in McRPC
Journal of Urology
Urology
Related publications
Simultaneous Quantitation of Abiraterone, Enzalutamide, N -Desmethyl Enzalutamide, and Bicalutamide in Human Plasma by LC–MS/MS
Journal of Pharmaceutical and Biomedical Analysis
Clinical Biochemistry
Drug Discovery
Analytical Chemistry
Spectroscopy
Pharmaceutical Science
Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer Patients
European urology oncology
Oncology
Radiology
Urology
Nuclear Medicine
Imaging
Surgery
Mp87-03 Targeted Gene Expression Profiling Within Circulating Tumor Cells in McRPC
Journal of Urology
Urology
Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-Resistant Prostate Cancer After Chemotherapy
Klinicka Onkologie
Oncology
Germline Variant in SLCO2B1 and Response to Abiraterone Acetate Plus Prednisone (AA) in New Onset Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Molecular Cancer Therapeutics
Cancer Research
Oncology
TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Taking Into Account Nucleosomes for Predicting Gene Expression
Methods
Biochemistry
Genetics
Molecular Biology
The Lack of a Relationship Between Physician Payments From Drug Manufacturers and Medicare Claims for Abiraterone and Enzalutamide
Cancer
Cancer Research
Oncology
Predicting Biomarkers for Ovarian Cancer Using Gene-Expression Microarrays
British Journal of Cancer
Cancer Research
Oncology
